scispace - formally typeset
D

David Dankort

Researcher at McGill University

Publications -  43
Citations -  4572

David Dankort is an academic researcher from McGill University. The author has contributed to research in topics: Receptor tyrosine kinase & Melanoma. The author has an hindex of 25, co-authored 42 publications receiving 4194 citations. Previous affiliations of David Dankort include University of California, San Francisco & McMaster University.

Papers
More filters
Journal ArticleDOI

BrafV600E cooperates with Pten loss to induce metastatic melanoma

TL;DR: These mice, engineered with a common genetic profile to human melanoma, provide a system to study melanoma's cardinal feature of metastasis and for preclinical evaluation of agents designed to prevent or treat metastatic disease.
Journal ArticleDOI

A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors

TL;DR: BRaf(CA) mice infected with an Adenovirus expressing Cre recombinase developed benign lung tumors that only rarely progressed to adenocarcinoma and BRaf(VE)-induced lung tumors were prevented by pharmacological inhibition of MEK1/2.
Journal ArticleDOI

A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma

TL;DR: It is shown that expression of BRAF(V600E), but not PIK3CA(H1047R), in the mouse pancreas leads to pancreatic intraepithelial neoplasia (PanIN) lesions, and RAF→MEK→ERK signaling is central to the initiation and maintenance of PDA and to rational combination strategies in this disease.
Journal ArticleDOI

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis

TL;DR: It is shown here that PTEN depletion abrogates BRAF(V600E)-induced senescence in human fibroblasts and melanocytes, and demonstrated that PI3K pathway activation serves as a rate-limiting event in this setting, acting at least in part by abrogating OIS.